Breast cancer precursors revisited: molecular features and progression pathways

MA Lopez‐Garcia, FC Geyer, M Lacroix‐Triki… - …, 2010 - Wiley Online Library
Lopez‐Garcia MA, Geyer FC, Lacroix‐Triki M, Marchió C & Reis‐Filho JS (2010)
Histopathology 57, 171–192 Breast cancer precursors revisited: molecular features and …

Molecular evolution of breast cancer

PT Simpson, JS Reis‐Filho, T Gale… - The Journal of …, 2005 - Wiley Online Library
Molecular analysis of invasive breast cancer and its precursors has furthered our
understanding of breast cancer progression. In the past few years, new multi‐step pathways …

[HTML][HTML] Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis

PWB Derksen, X Liu, F Saridin, H van der Gulden… - Cancer cell, 2006 - cell.com
Metastatic disease is the primary cause of death in breast cancer, the most common
malignancy in Western women. Loss of E-cadherin is associated with tumor metastasis, as …

[HTML][HTML] Lobular breast cancer: histomorphology and different concepts of a special spectrum of tumors

M Christgen, G Cserni, G Floris, C Marchio, L Djerroudi… - Cancers, 2021 - mdpi.com
Simple Summary Invasive lobular breast cancer (ILC) is a special type of breast cancer (BC)
that was first described in 1941. The diagnosis of ILC is made by microscopy of tumor …

The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004

CR Eheman, KM Shaw, AB Ryerson, JW Miller… - … Biomarkers & Prevention, 2009 - AACR
Background: National incidence rates for lobular and ductal breast cancers have not been
available previously. Evidence suggests that the increased risk of breast cancer associated …

Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision

MP Murray, C Luedtke, L Liberman, T Nehhozina… - Cancer, 2013 - Wiley Online Library
BACKGROUND: No consensus exists on the need to excise breast lesions that yield classic
lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)(known together as …

Lobular breast carcinoma and its variants

EA Rakha, IO Ellis - Seminars in diagnostic pathology, 2010 - Elsevier
Lobular carcinoma is a special type of breast cancer that shows distinct clinical presentation,
morphologic and molecular features, and clinical behavior, and its incidence is rising in …

Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice

PWB Derksen, TM Braumuller… - Disease models & …, 2011 - journals.biologists.com
Breast cancer is the most common malignancy in women of the Western world. Even though
a large percentage of breast cancer patients show pathological complete remission after …

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity

JS Reis‐Filho, PT Simpson, C Jones… - The Journal of …, 2005 - Wiley Online Library
Immunohistochemical analysis of E‐cadherin has changed the way lobular neoplasia is
perceived. It has helped to classify difficult cases of carcinoma in situ with indeterminate …

Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast–a review

M Hussain, GH Cunnick - European Journal of Surgical Oncology, 2011 - Elsevier
OBJECTIVES: To determine the incidence of malignancy (invasive carcinoma or DCIS) in
patients diagnosed with lobular neoplasia (B3) on core needle biopsy (CNB) of breast …